sites occur in actively transcribed genes [11] . Latency might also result after integration by the subsequent formation of heterochromatin about the provirus.
The host factors LSF and YY1 recruit HDAC-1 to a longterminal repeat (LTR) site, the repressor complex sequence [12] [13] [14] . HDAC1 recruitment can deacetylate the adjacent nucleosome 1 of the LTR and inhibit Tat activation, LTR expression, and viral production [15] [16] [17] . If HDAC recruitment contributes to HIV proviral quiescence, a blockade of repression might allow the outgrowth of HIV from latently infected resting CD4 + T cells.
No available experimental system recapitulates all aspects of quiescent HIV infection within primary resting CD4 + T cells.
Latency in cell-line models may be due to unique characteristics selected in culture [18] [19] [20] . Recently, HIV latency has been modeled in SCID-hu mice with transplanted thymic grafts [21] . Findings in this model system have suggested that specific signals may activate viral outgrowth without inducing T cell proliferation [22] . Studies of HIV latency have been performed in resting lymphocytes isolated from HIV-infected volunteers, but the mechanisms that regulate latency have not been fully described [2] [3] [4] [5] [6] [7] 23] . Pyrrole-imidazole polyamides, synthetic molecules that contain N-methylpyrrole and N-methylimidazole amino acids that are capable of binding to specific DNA sequences with affinities comparable to those of natural DNA-binding transcriptional regulatory proteins, can modulate gene expression [24] [25] [26] [27] [28] . We demonstrated that LTR-binding polyamides targeted to the repressor complex sequence block late SV40 transcription factor (LSF) binding, decrease the occupancy of LSF, increase histone H4 acetylation at the integrated LTR, and increase LTR expression in model systems of quiescent HIV infection [15, 29] (D.M.M., unpublished data). Of note, these effects depend on the specific binding sequence recognized by LTR-binding polyamides, because none of these effects are seen with control polyamides that differ from LTR-binding polyamides by a single residue and do not bind the LTR within the repressor complex sequence.
To test the relevance of transcriptional repression in the regulation of latent HIV, we tested the effect of polyamides on the expression of HIV in resting CD4 + cells obtained from HIVinfected donors. Polyamides targeted to the repressor complex sequence specifically allowed HIV outgrowth from these cells.
Mechanisms that recruit HDAC to the integrated HIV promoter may thus contribute to the regulation of expression of HIV. In agreement with the results of Brooks et al. [21] , our findings suggest that the expression of quiescent provirus may be induced without global T cell activation.
MATERIALS AND METHODS
Polyamide synthesis. Reagents and protocols for polyamide synthesis have been described elsewhere [30, 31] . All polyamides were characterized by 1 H nuclear magnetic resonance and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Informed consent was obtained from patients, and human-experimentation guidelines of the US Department of Health and Human Services were followed in the conduct of clinical research.
Polyamide induction of HIV in resting CD4 + cells. HIVinfected volunteers were enrolled after they provided informed consent. Peripheral blood mononuclear cells (PBMCs) were isolated from up to 200 mL of blood by density centrifugation. Highly purified resting CD4 + cells were obtained by negative selection by use of a CD4 + selection technique (Stem Cell Technologies), as described elsewhere [23] . Antibodies for fluorescence-activated cell sorting analysis were obtained from Becton Dickinson. A purity of у95% of CD4 + cells was routinely observed with !0.5% exhibiting activation markers.
Cells were maintained for 7 days in RPMI 1640 medium and 10% heat-inactivated fetal bovine serum (FBS; Hyclone Laboratories) before the exposure of resting cells to 4 mg
6 allogeneic irradiated PBMCs, and 100 U interleukin (IL)-2/mL [3] ; to 2 mmol/L the indicated repressor complex sequence (RCS)-binding or control polyamide and 20 U IL-2/mL; or to 20 U IL-2/mL alone. Supernatant was removed for p24 analysis 72 h later, and cultures were expanded with the addition of 10 6 activated, allogeneic CD8 + -depleted PBMCs from HIV-seronegative donors [3] . Cultures were fed with RPMI 1640 medium, FBS, and 20 U IL-2/mL, and supernatants were harvested every 2-3 days. Then, activated CD8 + -depleted, PBMCs 6 0.75-1.5 ϫ 10 from HIV-seronegative donors were added to cultures every 7 days. Virus was detected in culture supernatant by p24 antigencapture ELISA (AIDS Research and Reference Reagent Program).
Limiting-dilution cultures of resting CD4 + T cells obtained by leukopheresis were performed as described elsewhere [3, 23] , with the following modifications. After negative selection as described above, cells were cultured for 2- and p24 was assayed in culture supernatant as described above. Infectious units per 10 6 resting cells and associated 95% likelihood-based confidence intervals (CIs) were estimated by use of a maximum-likelihood method [32] .
Quantitation of integrated HIV DNA (Alu-LTR polymerase chain reaction [PCR] assay). Resting CD4
+ T cells were obtained from leukopheresis samples, and DNA was extracted (QIAmp DNA kit; Qiagen). Samples were analyzed by use of a highly sensitive nested PCR and liquid-hybridization assay specific for the integrated virus. PCR primers and conditions were as described elsewhere [3] . In brief, first-round PCR primers were directed at a conserved Alu site in the human genome and at the viral LTR. Threefold dilutions of genomic DNA were analyzed in quadruplicate to determine the approximate end point. Additional replicates were performed around the end point. The PCR products were detected by use of a 32 P endlabeled oligonucleotide probe (5 -GGATGGTGCTTCAAGITAG-TACC-3 ) that was internal to the HIV LTR and visualized by autoradiography. Unintegrated linear and circular HIV DNA is not amplified by use of this procedure. Assay controls included integrated DNA that was not amplified and DNA obtained from persistently infected ACH-2 cells that carry a single integrated copy of proviral DNA. The QUALITY program [33] was used to determine the number of HIV DNA integrants/ 10 6 resting CD4 + T cells. The lower limit of detection was 10 integrants/mg of total cellular DNA.
Heteroduplex mobility assay. HIV RNA was extracted from culture supernatant from the same number of resting cells at parallel time points in culture by use of the QuiAMP Viral RNA miniKit (Quiagen), and samples were treated with DNase (Ambion). For reverse-transcription PCR (Superscript One-Step; Invitrogen), primers from variable regions of gp120, V1-V2 (forward, 5 -ATGGGATCAAAGCCTAAAGCCA-3 ; reverse, 5 -CCTTTGGACAGGCCTGTGTAATG-3 ) were used for the first round of PCR. Then, 2 mL of product of this reaction was used for the second round of PCR (primers for VI-V2: forward, 5 -ATGGGATCAAAGCCTAAAGCCATGTG-3 ; reverse, 5 -CTT-TGGACAGGCCTGTGTAATGGCTGA-3 ), with 2 mL of annealing buffer (50 mmol Tris/L [pH 7.5], 500 mmol NaCl/L, and 25 mmol EDTA/L). The mixture was heated for 2 min at 94ЊC and transferred to ice for 3 min, to permit the formation of heteroduplexes. Heteroduplexes were visualized by ethidium bromide staining after electrophoretic separation on a 5% polyacrylamide gel. PCRs from the same RNA/DNA preparation were performed in triplicate and combined before electrophoresis, to ensure that a sufficient population of viral genes was present to accurately reflect the quasi species population. The heteroduplex mobility assay (HMA) was performed as described elsewhere [34] . In brief, 8 mL of second-round PCR product was combined.
RESULTS

Polyamides entering the nucleus of resting primary CD4
+ T cells but not activating them. Polyamides can enter the cell nucleus [35] , target a specific DNA sequence for cleavage by chlorambucil [35, 36] , and alter the occupancy of transcription factors at the HIV LTR within host chromatin within an unmanipulated human cell [29] . To confirm that polyamides access the nucleus of primary resting T lymphocytes, resting cells were isolated [23] and incubated in medium that contained 20 U IL-2/mL for 18 h in the presence of 5 mmol of Bodipy-labeled polyamide/L [31] . Serial cross-sectional images were obtained by confocal fluorescence microscopy.
Resting primary CD4 + T cells were small, with large nuclei and a scanty rim of cytoplasm (figure 1A and 1B). RCS-binding polyamides do not activate cells. Exposure to 2 mmol polyamides/L had no detectable effect on the expression of the cell-surface activation markers CD25, HLA-DR, CD69, CD38, or the nuclear proliferation antigen Ki67 (data not shown) in resting cells selected from 3 HIV-seropositive donors and 1 HIV-seronegative donor.
Replication of latent HIV within primary resting CD4 + T cells induced on exposure to RCS-binding polyamides. Polyamides (designated 1, 2, 3, and 4) targeted to 3 different regions within the repressor complex sequence of the HIV promoter (figure 2; see [29] for the structure of polyamides) block the recruitment of LSF to the LTR in chromatin immunoprecipitation assays, block the repression mediated by LSF and YY1, and upregulate the expression of LTR [29] . This activity is sequence specific-polyamides encoding a single residue change (designated M1, M2, and M3/4) do not bind the repressor complex sequence or affect the expression of LTR. Similarly, polyamides that bind the NF-kB region within the HIV-1 LTR [20] have no effect on adjacent LSF binding [29] . To demonstrate that the recruitment of HDAC by LSF and YY1 plays a role in the latent infection of primary CD4
+ T cells, we tested the ability of polyamides 1, 2, 3, or 4 and equimolar combinations of 1 or 2 and 3 or 4, to allow the expression of HIV from purified resting CD4 + T cells obtained from HIV-infected donors. Because there is interference in binding between polyamides 1 and 2 and between polyamides 3 and 4, these combinations were not tested.
Resting CD4 + T cells were isolated, and HIV outgrowth assays were performed as described in Materials and Methods [23] . Cells were exposed to LTR-binding polyamides and IL-2, control polyamides and IL-2, or IL-2 alone or were activated by PHA and IL-2. After 72 h, cells were cultured in a limitingdilution assay format, and activated, allogenic CD8 + -depleted PBMCs from HIV-seronegative donors were added to all cultures to allow the amplification and detection of virus expressed from cells.
Only resting cells could be obtained by phlebot- 6 4-12 ϫ 10 omy from each patient; therefore, resting cells/well 6 1-2 ϫ 10 were cultured. Because of limited numbers of cells, every condition could not be tested in every subject. Because latently infected CD4 + cells may be as rare as 0.5-10/10 6 cells, and in some cases even fewer, in these studies it is likely that some wells may not have received infected cells.
HIV was recovered from the cells from 22 donors when cells were treated with 1 or 2 RCS-binding polyamides as frequently as when they were treated with PHA. HIV was recovered more frequently when cultures were exposed to PHA or polyamides 1, 2, 3, or 4 than when they were unstimulated or treated with the mismatch polyamides M1, M2, or M3/4 (table 1; ). P ! .001 Outgrowth of latent HIV from the resting CD4 + T cells of persistently aviremic HIV-infected donors treated with highly active ART after exposure to RCS-binding polyamides. To avoid these confounding factors, we then studied outgrowth of HIV from resting CD4 + cells obtained from aviremic HIVinfected donors who were receiving optimal ART. In 5 subjects without detectable viremia (!50 copies HIV-1 RNA/mL), replication-competent HIV was never detected in control cultures. HIV was detected in 1 of 5 samples from patient after activation with PHA and in that patient's sample after exposure to RCSbinding polyamides. These findings suggest that binding polyamides could allow the outgrowth of latent HIV.
However, given the infrequency of latently infected cells [1] [2] [3] [4] [5] [6] [7] , we harvested larger numbers of cells by leukopheresis of samples from HIV-infected donors in whom plasma levels of HIV-1 RNA had been durably suppressed (16 months) to !50 copies/mL; lymphocytes were obtained from each 9 10-20 ϫ 10 patient, and resting CD4 + cells were isolated. 6 200-500 ϫ 10 Recently infected cells are rare in such donors [7, 23] . To further reduce the likelihood of the outgrowth of rare circulating or preintegrated virus, cells were maintained for 2-3 days in the presence of both an HIV integrase inhibitor and an HIV 
of nucleoside or nucleotide reverse-transcriptase (RT) inhibitors (N), nonnucleoside RT inhibitors (NN), and ritonavir-boosted protease inhibitors (bPI).
reverse-transcriptase inhibitor with which the donor had not been treated. This additional procedure prolongs the ex vivo manipulation of cells without growth factors or stimulation and is likely to have decreased the recovery of HIV in our assays. It thus increases the confidence that the HIV detected represents replication-competent, preintegrated HIV. Allogeneic CD8 + -depleted PBMCs obtained from an HIV-seronegative donor were then added, to allow the amplification and detection of rare replication-competent provirus in the resting cells of these aviremic patients.
The results of limiting-dilution outgrowth assays performed in 8 subjects (table 2) confirmed that only specific RCS-binding polyamides allow viral outgrowth from the resting cell reservoir, whereas control polyamides that contain a single altered residue do not. Replication-competent HIV was recovered from resting CD4 + cells in 6 of 8 samples from patients after exposure to polyamides that bind the RCS and in 7 of 8 patient samples exposed to mitogen. There was no observable difference in the frequency of viral outgrowth between binding polyamides; the largest number of experiments was performed by use of polyamide 2. In every sample from which HIV outgrowth was induced by exposure to binding polyamides, virus was also recovered after T cell activation. Outgrowth curves from 4 representative donors from whom virus was recovered from equivalent cell inputs are shown ( figure 3 ). The outgrowth of virus was generally observed during the second or third week of culture. Outgrowth in the presence of IL-2 alone or control polyamides with IL-2 was never observed. Control cultures remained without viral outgrowth for up to 2 weeks after the detection of virus in polyamide-treated or -activated cultures or for up to 28 days in culture. Under these conditions, HIV outgrowth was rare. From each subject, resting CD4 + cells were assayed in up to . This IUPM for each patient was calculated from the pool of all cultures exposed to binding polyamides (e.g., for patient 1, the positive and negative cultures exposed to polyamide 3, and the negative cultures exposed to polyamide 1 or polyamides 1 and 3).
To provide a frame of reference, we performed quantitative nested Alu PCR on each of these purified resting CD4 + cell samples (table 2) . The number of integrated proviral copies was !10 1 -10 3 integrated genomes/10 6 resting CD4 + cells. Low numbers of integrated proviral genomes were generally predictive of a low IUPM value; however, the IUPM after stimulation with PHA was up to 2.8 logs lower than the number of integrated viral genomes detected by PCR. This large excess of HIV DNA integrants, compared with the rarity of replication-competent HIV, is consistent with the recent finding that only 1% of the resting lymphocytes containing HIV DNA could be induced to express HIV [37] .
Equally diverse viral species recovered on polyamide derepression and PHA activation. Viral isolates recovered from resting T cells might differ after mitogen activation or exposure to binding polyamides. To compare the diversity of viral outgrowth species, we performed HMAs, which can identify variants with 12% sequence variation by their slower migration in native polyacrylamide gels [38] . Previously, this technique has been used to establish that very few variants can be recovered from patients' resting T cells after activation with PHA [23] . Assessing the highly variable V1-V2 region of the HIV env gene, we surveyed viral diversity in replication-competent virus recovered in outgrowth assays of resting CD4 + T cells from 4 aviremic patients that were exposed to binding polyamides or activated with PHA (figure 4). In samples from 3 of the patients, we observed 1 or 2 variants (single homoduplex or a homoduplex and 2 heteroduplexes; figure 4, lanes 1-10) . The number of variants was similar, irrespective of whether outgrowth was induced by exposure to binding polyamides or PHA activation.
The patients in the present study had been infected for 12 years and, as such, would be predicted to contain diverse HIV quasi species [39] . This diversity was reflected in the resting CD4 + T cells through the multiple heteroduplex species in some of the viral outgrowth samples analyzed (figure 4, lanes 6, 7, 9, 11, 12, 14, 15, and 16) . Diversity in the virus induced to replicate from the resting CD4 + T cells was also suggested from the samples that exhibited only a single homoduplex, because the homoduplexes from the same patient were observed to migrate differently in the acrylamide gel ( figure 4, lanes 1, 2, 3, and 4) . This result indicates the presence of insertions and deletions in the V1-V2 region of the env gene from this patient; these were verified by the use of additional HMAs (data not shown).
In each culture from which HIV was recovered after PHA activation or exposure to polyamides, viral populations were unique and distinct within the env V1-V2 region. It is of interest that, in 1 patient, multiple variants were seen in both the bind- + T cells and after stimulation with phytohemagglutinin (PHA). The heteroduplex mobility assay was performed to assess the V1-V2 region of the HIV env gene. Viral RNA was isolated from culture supernatant of resting CD4 + T cells obtained from 4 patients treated with binding polyamides (PA; lanes 1-3, 5, 7-9, and 11-13) or PHA (lanes 4, 6, 10, and 14-16) . Viral RNA was recovered on the same day from 16 cultures of equivalent numbers of resting cells. Triplicate polymerase chain reactions were combined and electrophoresed through a native acrylamide gel. Regions of the gel representing single strands, heteroduplexes (duplex of 2 genetically related but divergent DNA strands), and homoduplexes (duplex of genetically identical DNA strands) are indicated.
ing polyamide-and PHA-treated cultures (figure 4, lanes [11] [12] [13] [14] [15] [16] . Although the number of samples available for analysis was small, it does appear that the derepression mediated by RCSbinding polyamides allowed the expression of a variety of HIV variants at least comparable to the number recovered after PHA activation.
These analyses suggest that the greater frequency of viral outgrowth observed after PHA activation is not the result of the activation of more latent variants in resting T cell cultures. Viral production in cultures from the original population of HIV-infected donor cells in the setting of global T cell activation is likely increased, compared with the targeted derepression of the HIV promoter. Although binding polyamides induce a similar number of variants to replicate, without high-level production of virus, an inefficient transfer of infection to seronegative donor targets in outgrowth assays may occur, resulting in fewer positive cultures.
DISCUSSION
The present studies, which were performed directly in unmodified cells from HIV-infected patients, has shown that host factors within resting CD4 + T cells can restrict the expression of HIV in a biologically meaningful way. Pyrrole-imidazole polyamides are useful tools to modulate the DNA-binding activity of transcription factors, which allows mechanistic studies of the biological role of a targeted gene in living, unmanipulated cells. RCSbinding polyamides can inhibit LSF binding to the LTR in vitro and in vivo and increase the basal level of expression of the LTR [29] . Using these molecules, we have shown that a mechanism of transcriptional repression is operational within primary lymphocytes; RCS-binding polyamides specifically allowed the expression of latent HIV within primary resting CD4 + cells obtained from HIV-infected donors. HDAC recruitment to the LTR must therefore play a role in the maintenance of viral quiescence within resting CD4 + T cells. HIV outgrowth in cultures exposed to LTR-binding polyamides is not the result of nonspecific cell activation or the up-regulation of cellular genes-4 distinct polyamides targeted to 3 significantly different sequences within the RCS (figure 2) specifically activated LTR expression and allowed virus production from resting CD4 + cells, but 3 control, mismatched polyamides containing a single altered residue did not. It is important to recognize the sequence specificity of this effect, given that 3 of 4 binding polyamides targeted completely different sequences within the general region in which LSF binds, whereas the control nonbinding polyamides did not bind within the RCS, yet both groups of molecules bound at numerous sites within the genome. However, any single binding polyamide can induce viral expression.
Furthermore, polyamides do not nonspecifically improve the infection of allogeneic feeder cells added during the outgrowth phase of experiments or enhance the production of virus or proliferation of cells grown in IL-2, because the exposure of activated PBMCs to binding polyamides during HIV infection does not measurably alter viral output (data not shown). Additionally, the exposure of cells to polyamides has no effect on resting CD4
+ cell morphology or surface-marker expression. We cannot exclude the possibility that IL-2 has a contributory effect to the ability of RCS-binding polyamides to induce viral outgrowth in resting cells from patients with HIV. However, despite the provision of activated target cells and IL-2, control polyamides did not facilitate the outgrowth of latent HIV.
Dudouet et al. [35] recently measured the effect of 2 polyamides that target similar sequences that occur in the genome every ∼2000 bp. Global gene-expression analysis of ∼18,000 genes found that these polyamides affected 21 genes: 11 genes were inhibited by 1 of the polyamides, and 10 genes were inhibited by both polyamides; however, no genes were activated. The largest change observed was a 2.7-fold down-regulation. Although subtle effects of polyamides on the host cell cannot be ruled out, HIV outgrowth was allowed by 4 RCS-binding polyamides recognizing 3 unique sequences but not by 3 control polyamides of similar composition but slightly altered sequence specificity, and this is not likely to have been due to the modulation of host gene expression.
Our results clearly illustrate a role for transcriptional repression in the regulation of HIV expression. It is not yet clear whether inhibition of the HDAC function in vivo will be sufficient to induce the expression of latent HIV. HDAC inhibition augments HIV LTR expression in cell line models of latency [9] . Recently, in assays similar to those described here, our laboratory found that replication-competent HIV can be recovered from cells from patients after ex vivo exposure to an HDAC inhibitor [40] .
Attempts have been made to purge the resting cell reservoir of HIV infection through the use of simultaneous immune activation and intensive ART [41] [42] [43] [44] . Subsequent modeling studies have suggested that, under such conditions, viral replication might be activated beyond the threshold that can be contained by ART [45] . It may be difficult to use therapies to purge the resting cell reservoir that induce nonspecific T cell activation without unintended deleterious consequences. In a thymic explant model, it has recently been shown that IL-7 can induce the expression of latent HIV without inducing cellular proliferation [22] .
Current ART is not yet potent enough to block all active HIV replication [46] [47] [48] [49] [50] , but, with improvements in ART, this goal might be achieved. In the future, intensive but time-limited ART, if coupled with therapies designed to induce the expression of latent HIV, might allow the clearance of HIV infection.
